Hints and tips:
...Yet healthcare stocks have largely shrugged off the news. The absence of a market spasm this time around is telling....
...But technology stocks took a beating in the spring and private financing is drying up....
...Downside risks include a drop in US Gx sales as highlighted by our latest Rx data analysis, while gVascepa is not a done deal in our view despite market optimism....
...The 32-year-old from Minnesota is one of a busload of diabetics who have made the journey from the US to a pharmacy in Canada to stock up on vital supplies of the drug insulin....
...Walgreens Boots Alliance’s stock price fell 9.9 per cent. “Amazon is already eroding their retail business and this is definitely another threat,” says Ana Gupte, analyst at Leerink....
...GAC said in a filing to the Hong Kong Stock Exchange that the two companies would jointly develop internet-connected cars and artificial intelligence-aided driving....
...In reality, it's scarcity that is propelling stocks to record highs....
...The report cited unnamed sources who said that additional individuals may also be charged, including people at Philidor Rx Services, a specialty pharmacy company that has been linked to the conduct being...
...Samir Devani, analyst at Rx Securities in London, expects peak sales for the drug of more than €700m....
...Shares in Concordia, listed on the Toronto stock exchange, are down more than a third this year....
...In September, Mrs Clinton took to Twitter and pledged to crack down on “outrageous price gouging” in the prescription drugs industry, a declaration that sparked a sharp sell-off of pharma sector stocks,...
...With pharmaceutical stocks in a tailspin, Ian Read, chief executive of Pfizer, sought to reassure his shareholders....
...It has faced scrutiny for its relationship with specialty pharmacies such as Philidor Rx, with which it cut ties in late October....
...UnitedHealth, which is offering $61.50 a share, is planning to merge Catamaran with its Optum Rx unit, the sector’s number three....
...The combined business will have an improved Rx / Cx balance and increased investment opportunities....
...Leases on hundreds of thousands of luxury cars written during the heady days of the property and stock market boom are now expiring....
...Last March, RX Capital Management wound up its healthcare fund, which it had launched in 2002 and which reached a peak at $650m....
...CVS, the second-biggest US pharmacy chain, on Wednesday agreed to acquire Caremark Rx, a leading pharmacy benefits manager, for $21bn....
...Express Scripts on Tuesday launched a formal $25bn hostile offer for Caremark Rx, its larger rival in the US drug benefits management sector....
...The proposed tie-up of retail pharmacy chain CVS and Caremark Rx, the drug benefits manager, is billed as a merger of equals....
...“Being a stock-for-stock transaction, the value Caremark’s shareholders will ultimately receive depends on where the price of CVS’s stock goes and it is premature to say they won’t ultimately receive a premium...
...Express Scripts shed 6.7 per cent to $68.96, Caremark Rx tumbled 4.1 per cent to $51.19, and Medco Health Solutions dropped 2.4 per cent to $55.75....
...Medco Health Solutions slid 3.8 per cent to $60.48, and Caremark Rx sank4.3 per cent to $56.56. Crude oil futures ticked higher again, boosting energy stocks....
...The biggest deal to be announced involved the $21bn merger between pharmacy chain CVS and pharmacy-benefits manager Caremark Rx, with CVS exchanging 1.67 shares for each share of Caremark....
International Edition